Nuveen Asset Management, LLC Amicus Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $340 Billion
  • Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 3,807,420 shares of FOLD stock, worth $26.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,807,420
Previous 3,648,281 4.36%
Holding current value
$26.6 Million
Previous $39 Million 7.95%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$9.36 - $12.01 $1.49 Million - $1.91 Million
159,139 Added 4.36%
3,807,420 $35.9 Million
Q3 2024

Nov 14, 2024
BUY
$9.55 - $12.09 $16.7 Million - $21.1 Million
1,748,774 Added 92.06%
3,648,281 $39 Million
Q2 2024

Aug 09, 2024
BUY
$9.04 - $11.75 $6.8 Million - $8.84 Million
751,963 Added 65.53%
1,899,507 $18.8 Million
Q1 2024

May 13, 2024
SELL
$11.43 - $14.24 $2.91 Million - $3.63 Million
-255,028 Reduced 18.18%
1,147,544 $13.5 Million
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $1.61 Million - $2.35 Million
161,746 Added 13.04%
1,402,572 $19.9 Million
Q3 2023

Nov 14, 2023
BUY
$11.78 - $13.86 $5.02 Million - $5.91 Million
426,144 Added 52.31%
1,240,826 $15.1 Million
Q2 2023

Aug 14, 2023
BUY
$10.72 - $13.3 $47,982 - $59,530
4,476 Added 0.55%
814,682 $10.2 Million
Q1 2023

May 15, 2023
SELL
$10.91 - $13.54 $1.8 Million - $2.24 Million
-165,086 Reduced 16.93%
810,206 $8.99 Million
Q4 2022

Feb 14, 2023
SELL
$9.89 - $12.7 $1.54 Million - $1.97 Million
-155,443 Reduced 13.75%
975,292 $11.9 Million
Q3 2022

Nov 14, 2022
SELL
$9.82 - $12.75 $1.29 Million - $1.68 Million
-131,828 Reduced 10.44%
1,130,735 $11.8 Million
Q2 2022

Aug 15, 2022
BUY
$6.23 - $11.12 $1.06 Million - $1.89 Million
169,893 Added 15.55%
1,262,563 $13.6 Million
Q1 2022

May 16, 2022
SELL
$7.89 - $12.48 $2.96 Million - $4.69 Million
-375,481 Reduced 25.58%
1,092,670 $10.5 Million
Q4 2021

Feb 14, 2022
SELL
$9.82 - $12.44 $1.54 Million - $1.96 Million
-157,321 Reduced 9.68%
1,468,151 $15 Million
Q3 2021

Nov 12, 2021
SELL
$8.74 - $11.84 $2.71 Million - $3.67 Million
-310,165 Reduced 16.02%
1,625,472 $17.9 Million
Q2 2021

Aug 16, 2021
SELL
$8.71 - $10.72 $3.02 Million - $3.72 Million
-346,769 Reduced 15.19%
1,935,637 $18.7 Million
Q1 2021

May 17, 2021
SELL
$9.2 - $23.86 $3.48 Million - $9.03 Million
-378,628 Reduced 14.23%
2,282,406 $22.6 Million
Q4 2020

May 17, 2021
BUY
$13.47 - $24.89 $1.51 Million - $2.8 Million
112,347 Added 4.41%
2,661,034 $61.4 Million
Q4 2020

Feb 16, 2021
SELL
$13.47 - $24.89 $2 Million - $3.69 Million
-148,356 Reduced 5.5%
2,548,687 $58.8 Million
Q3 2020

Nov 16, 2020
SELL
$12.89 - $15.89 $2.65 Million - $3.27 Million
-205,939 Reduced 7.09%
2,697,043 $38.1 Million
Q2 2020

Aug 14, 2020
SELL
$8.86 - $15.69 $1.15 Million - $2.04 Million
-130,178 Reduced 4.29%
2,902,982 $43.8 Million
Q1 2020

May 14, 2020
SELL
$6.63 - $11.16 $7.44 Million - $12.5 Million
-1,121,611 Reduced 27.0%
3,033,160 $28 Million
Q4 2019

Feb 14, 2020
BUY
$7.48 - $10.75 $15 Million - $21.5 Million
2,000,176 Added 92.83%
4,154,771 $40.5 Million
Q3 2019

Nov 14, 2019
SELL
$8.02 - $13.25 $6.4 Million - $10.6 Million
-797,926 Reduced 27.03%
2,154,595 $17.3 Million
Q2 2019

Aug 15, 2019
BUY
$10.96 - $14.4 $32.4 Million - $42.5 Million
2,952,521 New
2,952,521 $36.8 Million

Others Institutions Holding FOLD

# of Institutions
301
Shares Held
322M
Call Options Held
396K
Put Options Held
249K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $1.96B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email